Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled OGM Making its Mark in Constitutional Genetic Disorders. Presentations highlighted how ...
Explore essential statistical strategies for accurate protein quantification and differential expression analysis.
Multiplexing Breakthroughs, Automation, and Bioinformatics Convergence Position Protein Microarrays as a Strategic Imperative for Precision Medicine LeadersDelray Beach, FL, Feb. 24, 2026 (GLOBE ...
The panel ensures compatibility with our previous autosomal Family Finder tests plus all the autosomal transfers we ...
BioVenic is dedicated to advancing the advancement of veterinary molecular diagnostics through its comprehensive ...
Growing Adoption of Growth Hormone Therapy, Expanding Estrogen Replacement Programs, and Government-Backed Rare Disease Initiatives Accelerate Turner Syndrome Market Growth.Austin, United States, Feb.
The global scar treatment market is growing robustly, expected to be valued at around US$ 23.0 billion in 2026 and projected to reach US$ ...
Increase in prevalence of genetic disorders, shift towards personalized medicine, and surge in demand for forensic DNA analysis are the major factors which drive the global genotyping market ...
The growth of the genomics market is driven by the rising prevalence of genetic disorders and cancer, along with increasing awareness of early disease detection through genetic testing. WILMINGTON, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results